There is no definite and convincing evidence that the use of the Granulocyte Colony-Stimulating Factor (G-CSF) or the Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF) before or during radiotherapy of head and neck cancer or chemotherapy exhibits therapeutic benefits in oral mucositis. This evidence concerns the gene CSF2 and oral mucositis.